ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,227Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1006

$1.35M Total Retail Price of All Prescriptions

Rank: 19 out of 1006

574 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 14,252 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 847 646 1 1
AMLODIPINE BESYLATE 706 581 2 4
LEVOTHYROXINE SODIUM 615 481 3 2
FUROSEMIDE 587 420 4 6
LISINOPRIL 488 375 5 3
ATORVASTATIN CALCIUM 441 379 6 5
WARFARIN SODIUM 415 214 7 8
METFORMIN HCL 392 295 8 10
METOPROLOL TARTRATE 384 322 9 7
POTASSIUM CHLORIDE 381 270 10 30
LANTUS 311 233 11 43
RISPERIDONE 293 208 12 40
GLIPIZIDE 277 224 13 69
GABAPENTIN 270 125 14 20
TRAZODONE HCL 258 213 15 21
METOPROLOL SUCCINATE 254 221 16 12
QUETIAPINE FUMARATE 243 214 17 45
OMEPRAZOLE 221 174 18 9
TAMSULOSIN HCL 199 151 19 23
ESCITALOPRAM OXALATE 193 136 20 27
OLANZAPINE 193 138 20 68
CITALOPRAM HBR 187 156 22 24
CLOZAPINE 186 103 23 107
BACLOFEN 183 70 24 95
SERTRALINE HCL 176 105 25 19
LEVETIRACETAM 173 108 26 72
LACTULOSE 172 91 27 104
NEXIUM 158 134 28 28
MIRTAZAPINE 147 146 29 26
PREDNISONE 143 96 30 33
ALENDRONATE SODIUM 140 94 31 29
TRAVATAN Z 140 109 31 131
RANITIDINE HCL 136 83 33 63
DIVALPROEX SODIUM 135 76 34 53
DONEPEZIL HCL 130 130 35 17
CARVEDILOL 127 64 36 36
GLIMEPIRIDE 118 98 37 50
HYDROCHLOROTHIAZIDE 116 96 38 11
ATENOLOL 115 106 39 13
DIOVAN 114 114 40 16
CYMBALTA 113 53 41 41
CLOPIDOGREL 110 107 42 46
ALLOPURINOL 109 93 43 31
OXYBUTYNIN CHLORIDE 97 75 44 197
HYDRALAZINE HCL 96 79 45 100
ADVAIR DISKUS 95 54 46 37
ACTOS 94 80 47 89
CARBIDOPA-LEVODOPA 93 62 48 80
PANTOPRAZOLE SODIUM 91 61 49 32
DILTIAZEM 24HR CD 90 78 50 88
PLAVIX 90 85 50 61
BENZTROPINE MESYLATE 90 73 R 50 106
JANUVIA 89 66 53 49
NAMENDA 86 82 54 34
EXELON 81 79 55 99
TRICOR 79 66 56 101
SEROQUEL 79 70 56 97
LIDODERM 78 55 58 66
PROPRANOLOL HCL 77 62 59 167
TRIAMTERENE-HCTZ 73 45 60 58
PAROXETINE HCL 73 53 60 62
SPIRIVA 73 60 60 48
METOCLOPRAMIDE HCL 73 50 60 134
PRAVASTATIN SODIUM 71 63 64 15
NOVOLIN R 69 60 65 158
IPRATROPIUM-ALBUTEROL 67 23 66 73
QUINAPRIL HCL 67 47 66 86
EVISTA 67 67 66 169
LABETALOL HCL 62 33 69 164
PHENYTOIN SODIUM EXTENDED 61 42 70 149
ABILIFY 60 40 71 102
CRESTOR 60 54 71 18
GLIPIZIDE ER 60 60 71 108
DIGOXIN 60 60 71 52
LIPITOR 60 57 71 47
MELOXICAM 60 50 71 67
CIPROFLOXACIN HCL 57 42 77 75
CHLORHEXIDINE GLUCONATE 56 40 78 136
HUMALOG 55 33 79 116
IBUPROFEN 55 20 79 114
LEVOFLOXACIN 53 49 81 96
DOXAZOSIN MESYLATE 53 42 81 87
SPIRONOLACTONE 53 42 81 71
CICLOPIROX 51 40 84 383
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.